Liver Disease / Hepatitis News From Medical News Today
Increased Risk Of Fatal Side Effects From 3 'Targeted' Cancer Drugs Treatment with three relatively new "targeted" cancer drugs has been linked to a slightly elevated chance of fatal side effects, according to a new analysis led by scientists at Dana-Farber Cancer Institute. They added that the risk remains low, but should be taken into account by physicians and patients. The incidence of fatal complications was 1...
For Patients With Primary Biliary Cirrhosis, Rituximab A Possible Treatment Option An open-label study of rituximab, a monoclonal antibody for human CD20, was shown to be safe in patients with primary biliary cirrhosis (PBC) who had an incomplete response to the standard ursodeoxycholic acid (UDCA) therapy, also known as Ursodiol...
Coffee Consumption Reduces Fibrosis Risk In Those With Fatty Liver Disease Caffeine consumption has long been associated with decreased risk of liver disease and reduced fibrosis in patients with chronic liver disease. Now, newly published research confirms that coffee caffeine consumption reduces the risk of advanced fibrosis in those with nonalcoholic fatty liver disease (NAFLD)...
Hepatitis Research May Benefit From Stem Cells Hepatitis C is a viral disease that leads to inflammation and organ failure. However, researchers are puzzled as to why some individuals are very susceptible to the disease, while others are not. Researchers believe they could find out how genetic variations produce these different responses by investigating liver cells from different individuals in the lab...
Stem Cells Could Drive Hepatitis Research Forward Hepatitis C, an infectious disease that can cause inflammation and organ failure, has different effects on different people. But no one is sure why some people are very susceptible to the infection, while others are resistant. Scientists believe that if they could study liver cells from different people in the lab, they could determine how genetic differences produce these varying responses...
Recommendations For HPV And Hepatitis B Vaccinations Broadened By 2012 Adult Immunization Schedule The CDC's Advisory Committee on Immunization Practices (ACIP) now recommends routine HPV vaccination for males aged 11 to 12 years and catch-up vaccination for males aged 13 to 21. These are just two of the changes to the 2012 Recommended Adult Immunization Schedule published February 1 in Annals of Internal Medicine, the flagship journal of the American College of Physicians (ACP)...
New Information In The Fight Against Flu Influenza virus can rapidly evolve from one form to another, complicating the effectiveness of vaccines and anti-viral drugs used to treat it...
Researchers Discover New Therapeutic Target To Combat Liver Cancer Researchers at CIC Biogune, the Cooperative Centre for Research into Biosciences and led by Dr. Maria Luz Martinez Chantar, have found a strong relationship between high levels of Hu antigen R (HuR) protein and the malignancy of Hepatocellular Carcinoma, through a novel molecular process in the investigation of this pathology and known as neddylation...
المعلوما
ت الطبيه للثقافه الطبيه و لا تغنى عن استشاره الطبيب تمت
مراجعه هذا الجزء بواسطه دكتور اسامه
الحصيوى شروط
استخدام
الموقع و
سياسه الخصوصيه اخر
تحديث بتاريخ 25 يونيو 2008